Dual PI3K/mTOR inhibitor NVP-BEZ235 enhances radiosensitivity of head and neck squamous cell carcinoma (HNSCC) cell lines due to suppressed Double-Strand Break (DSB) repair by non-homologous end joining

Schötz, Ulrike; Balzer, Viola; Brandt, Friedrich-Wilhelm; Ziemann, Frank GND; Subtil, Florentine S.B.; Rieckmann, Thorsten GND; Köcher, Sabrina; Engenhart-Cabillic, Rita GND; Dikomey, Ekkehard GND; Wittig, Andrea GND; Arenz, Andrea

The PI3K/Akt/mTOR pathway is frequently altered in human papillomavirus (HPV)-positive and negative squamous cell carcinoma of the head and neck (HNSCC) and overstimulation is associated with poor prognosis. PI3K drives Akt activation and constitutive signaling acts pro-proliferative, supports cell survival, DNA repair, and contributes to radioresistance. Since the small molecule NVP-BEZ235 (BEZ235) is a potent dual inhibitor of this pathway, we were interested whether BEZ235 could be an efficient radiosensitizer. The 50 nM BEZ235 was found to abrogate endogenous and irradiation-induced phosphorylation of Akt (Ser473). The anti-proliferative capacity of the drug resulted in an increase in G1-phase cells. Repair of radiation-induced DNA double-strand breaks (DSBs) was strongly suppressed. Reduction in DSB repair was only apparent in G1- but not in G2-phase cells, suggesting that BEZ235 primarily affects non-homologous end joining. This finding was confirmed using a DSB repair reporter gene assay and could be attributed to an impaired phosphorylation of DNA-PKcs (S2056). Cellular radiosensitivity increased strongly after BEZ235 addition in all HNSCC cell lines used, especially when irradiated in the G0 or G1 phase. Our data indicate that targeting the PI3K/Akt/mTOR pathway by BEZ235 with concurrent radiotherapy may be considered an effective strategy for the treatment of HNSCC, regardless of the HPV and Akt status.

Cite

Citation style:
Schötz, U., Balzer, V., Brandt, F.-W., Ziemann, F., Subtil, F.S.B., Rieckmann, T., Köcher, S., Engenhart-Cabillic, R., Dikomey, E., Wittig, A., Arenz, A., 2020. Dual PI3K/mTOR inhibitor NVP-BEZ235 enhances radiosensitivity of head and neck squamous cell carcinoma (HNSCC) cell lines due to suppressed Double-Strand Break (DSB) repair by non-homologous end joining. Cancers 12, 2020, S. 467:1-467:15. https://doi.org/10.3390/cancers12020467
Could not load citation form. Default citation form is displayed.

Rights

License Holder: © 1996-2020 MDPI (Basel, Switzerland)

Use and reproduction:

Export